MLA
TMDX icon

MB, Levis & Associates’s Transmedics TMDX Stock Holding History

MB, Levis & Associates’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.9K Buy
+200
New +$26.1K 0.01% 141

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MB, Levis & Associates's TMDX Position: Q1 2026 in Review

MB, Levis & Associates opened a new position in Transmedics (TMDX) in Q1 2026: 200 shares worth $19.9K. The stake represents 0.01% of the portfolio and ranks #141 among its holdings.

414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • MB, Levis & Associates held 200 shares of Transmedics worth $19.9K as of Q1 2026.
  • Transmedics was a new MB, Levis & Associates position in Q1 2026.
  • Transmedics made up 0.01% of MB, Levis & Associates's portfolio in Q1 2026, its #141 holding.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on MB, Levis & Associates's 13F filing for Q1 2026, filed 8 Apr 2026.